Johnson Investment Counsel’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-3,433
| Closed | -$527K | – | 681 |
|
2023
Q1 | $527K | Buy |
3,433
+1,414
| +70% | +$217K | 0.01% | 449 |
|
2022
Q4 | $363K | Sell |
2,019
-103
| -5% | -$18.5K | ﹤0.01% | 514 |
|
2022
Q3 | $251K | Buy |
2,122
+99
| +5% | +$11.7K | ﹤0.01% | 567 |
|
2022
Q2 | $289K | Hold |
2,023
| – | – | ﹤0.01% | 554 |
|
2022
Q1 | $348K | Sell |
2,023
-1,018
| -33% | -$175K | ﹤0.01% | 546 |
|
2021
Q4 | $772K | Buy |
3,041
+107
| +4% | +$27.2K | 0.01% | 383 |
|
2021
Q3 | $1.13M | Buy |
2,934
+104
| +4% | +$40K | 0.02% | 324 |
|
2021
Q2 | $665K | Sell |
2,830
-15
| -0.5% | -$3.53K | 0.01% | 384 |
|
2021
Q1 | $373K | Buy |
2,845
+150
| +6% | +$19.7K | 0.01% | 475 |
|
2020
Q4 | $282K | Sell |
2,695
-2,185
| -45% | -$229K | ﹤0.01% | 506 |
|
2020
Q3 | $345K | Buy |
+4,880
| New | +$345K | 0.01% | 445 |
|